Life Sciences Litigation Trendspotting: A Look at Key Court Decisions Impacting the Life Sciences Industry in 2024 and Critical Takeaways for Your Practice

Product liability and mass torts partner Christine Kain participated in a panel at the Women Leaders in Life Sciences Law conference titled, “Life Sciences Litigation Trendspotting: A Look at Key Court Decisions Impacting the Life Sciences Industry in 2024 and Critical Takeaways for Your Practice.”

 In the session, the panelists walked through the top 10 court cases impacting the life sciences industry in the last year and their implications. The cases spanned all sectors of the life sciences arena, including IP, product liability, antitrust and more. Cases discussed included Loper Bright Enterprises v. Raimondo; Relentless v. Department of Commerce; FDA v. Alliance for Hippocratic Medicine; and Gilead Sciences, Inc. v. Superior Court of City & County of San Francisco.